Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems
Frontiers in Cellular and Infection Microbiology · 10.01.2023 · 12
DOI: 10.3389/fcimb.2022.1065561 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 10.01.2023. Verfasst von Nadja Blasey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Immunology, Ruhr-University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Type IV Secretion Systems, Bacteria. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Infections caused by Gram-negative pathogens pose a major health burden. Both respiratory and gastrointestinal infections are commonly associated with these pathogens. With the increase in antimicrobial resistance (AMR) over the last decades, bacterial infections may soon become the threat they have been before the discovery of antibiotics. Many Gram-negative pathogens encode virulence-associated Type III and Type IV secretion systems, which they use to inject bacterial effector proteins across bacterial and host cell membranes into the host cell cytosol, where they subvert host cell functions in favor of bacterial replication and survival. These secretion systems are essential for the pathogens to cause disease, and secretion system mutants are commonly avirulent in infection models. Hence, these structures present attractive targets for anti-virulence therapies. Here, we review previously and recently identified inhibitors of virulence-associated bacterial secretions systems and discuss their potential as therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Immunology, Ruhr-University Bochum, Bochum, Germany.
Zitieren
APA
Blasey, N., Rehrmann, D., Riebisch, A. K., & Mühlen, S. (2023). Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.1065561
Vancouver
Blasey N, Rehrmann D, Riebisch AK, Mühlen S. Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems. Frontiers in Cellular and Infection Microbiology. 2023;12. doi:10.3389/fcimb.2022.1065561
BibTeX
@article{Blasey2023,
author = {Blasey, Nadja and Rehrmann, Daria and Riebisch, Anna Katharina and Mühlen, Sabrina},
title = {Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
volume = {12},
doi = {10.3389/fcimb.2022.1065561}
}
EUVIMED